Japanese Takeda to acquire Shire for $62bn

08-05-2018

Japanese Takeda to acquire Shire for $62bn

NicoElnino / iStockphoto.com

Japanese pharmaceutical company Takeda has agreed to acquire biotech company Shire for $62 billion.


Takeda, Shire, pharmaceutical acquisition, Adderall, overseas acquisition, oncology, gastroenterology, rare diseases, central nervous system disease area

LSIPR